Soc. Generale Knock-Out BIO/ DE000SU0TV56 /
19/11/2024 12:47:18 | Chg.-0.38 | Bid13:47:18 | Demandez à13:47:18 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
5.80EUR | -6.15% | 5.83 Bid taille: 2,000 |
6.42 Ask la taille: 2,000 |
Bio Rad Laboratories... | 246.1132 USD | 31/12/2078 | Call |
GlobeNewswire
12/08
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection i...
GlobeNewswire
24/06
Oncocyte Bolsters Executive Team with Key CFO Appointment: PRISM MarketView Highlights Strategic Lea...
GlobeNewswire
03/06
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte's VitaGraft Study
GlobeNewswire
29/03/2022
Fluidigm Announces Support Agreement with Caligan Partners Related to $250 Million Strategic Capital...
GlobeNewswire
22/03/2022
Iridia Announces Appointment of Thomas H. Cauley, Ph.D. as Vice President, Engineering
GlobeNewswire
03/08/2021
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
GlobeNewswire
01/06/2021
RNA Disease Diagnostics Further Strengthens Executive Leadership with Appointment of John W. Erickso...
GlobeNewswire
24/08/2020
Landec Nominates Three New Members to its Board of Directors, Providing Deep Expertise to Both Busin...
GlobeNewswire
04/05/2020
Alexis RIDEAU appointed Chief Executive Officer of DEINOVE with the ambition to strengthen the Comp...
Newsfile Corp
16/04/2020
LexaGene CEO Discusses COVID-19 Testing, Commercialization Strategy -- SECFilings.com
GlobeNewswire
20/03/2020
Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors
Newsfile Corp
09/03/2020
Coronavirus Highlights Need for Rapid Testing of Pathogens -- SECFilings.com
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page